|
rs17635492
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
|
23478653 |
2014 |
|
rs17635492
|
|
|
0.800 |
GeneticVariation |
GWASDB |
A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
|
23478653 |
2014 |
|
rs2018683
|
|
|
0.800 |
GeneticVariation |
GWASDB |
A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
|
23478653 |
2014 |
|
rs2018683
|
|
T |
0.800 |
GeneticVariation |
GWASCAT |
A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
|
23478653 |
2014 |
|
rs344924
|
|
|
0.800 |
GeneticVariation |
GWASDB |
A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
|
23478653 |
2014 |
|
rs344924
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
|
23478653 |
2014 |
|
rs7186128
|
|
G |
0.800 |
GeneticVariation |
GWASCAT |
A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
|
23478653 |
2014 |
|
rs7186128
|
|
|
0.800 |
GeneticVariation |
GWASDB |
A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
|
23478653 |
2014 |
|
rs10429489
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations.
|
31326317 |
2019 |
|
rs11674251
|
|
|
0.700 |
GeneticVariation |
GWASDB |
The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations.
|
21866343 |
2012 |
|
rs1209950
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel.
|
21079520 |
2011 |
|
rs12296850
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in han chinese.
|
23341777 |
2013 |
|
rs1454694
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A genetic polymorphism rs1454694 was identified as a novel genetic risk factor for RFS of stage I NSCLCs.
|
24737549 |
2014 |
|
rs10503380
|
|
|
0.010 |
GeneticVariation |
BEFREE |
TNKS1 SNPs (rs11991621 rs10503380, and rs7015700) were associated with NSCLC risk, whereas rs6601328 and rs12541709 inversely associated with NSCLC or ADC risk in this Chinese population.
|
26617760 |
2015 |
|
rs10878232
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Using online databases, we found rs10878232 displayed expression quantitative trait loci correlation with the expression of LEMD3, a neighboring gene previously associated with NSCLC survival.
|
24980784 |
2014 |
|
rs11646213
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our results indicated that the rs11646213 and rs7195409 in <i>CDH13</i> could be associated with NSCLC</span> or its pathologic stages in the Chinese Han population.
|
29416663 |
2018 |
|
rs11991621
|
|
|
0.010 |
GeneticVariation |
BEFREE |
TNKS1 SNPs (rs11991621 rs10503380, and rs7015700) were associated with NSCLC risk, whereas rs6601328 and rs12541709 inversely associated with NSCLC or ADC risk in this Chinese population.
|
26617760 |
2015 |
|
rs12000445
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The minor allele of three SNPs (rs7629386 at 3p22.1, rs969088 at 5p14.1, and rs3850370 at 14q24.3) were associated with worse NSCLC survival while 2 (rs41997 at 7q31.31 and rs12000445 at 9p21.3) were associated with better NSCLC survival.
|
22872573 |
2012 |
|
rs12621220
|
|
|
0.010 |
GeneticVariation |
BEFREE |
For rs12621220G>A (-3893) and rs1143623G>C (-1464), heterozygous variants, when compared with ancestral genotype, were significantly associated with decreased risk of NSCLC, with adjusted odds ratio (aOR)=0.710 (0.516, 0.976), P=0.035 and aOR=0.643 (0.466, 0.886), P=0.007, respectively.
|
26141218 |
2015 |
|
rs12621220
|
|
|
0.010 |
GeneticVariation |
BEFREE |
IL1B rs12621220G/A (-3893), rs1143623G/C (-1464), rs16944T/C (-511) and rs1143627C/T (-31) were previously reported to be associated with non-small cell lung cancer (NSCLC) and formed a specific haplotype (GGCT) which was associated with increased IL1B gene expression and increased risk of NSCLC in European populations.
|
26141218 |
2015 |
|
rs1414493
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our results showed that SDHC gene: SNP rs12064957, IDH2 gene: SNP rs11540478 and FH gene: SNP rs1414493 were associated with overall survival (OS) and SDHA gene: SNP rs13173911, IDH2 gene: SNP rs4932158 were associated with recurrence-free survival (RFS) of NSCLC patients.
|
25576295 |
2015 |
|
rs1957860
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We, therefore, performed a case-control study to investigate the association of seven selected single nucleotide polymorphisms (SNPs), in genes coding for excision repair cross-complimentary group 1 (ERCC1: rs11615, rs3212986, rs2298881), nuclear factor ĸB (NFKB2: rs7897947, rs12769316), bone morphogenetic protein 4 (BMP4: rs1957860), complement receptor 1 (CR1: rs7525160) and del/ins polymorphism in the family hypoxia inducible factor 2 gene (EGLN2: rs10680577), with non-small cell lung cancer (NSCLC) risk.
|
31177178 |
2019 |
|
rs2270628
|
|
|
0.010 |
GeneticVariation |
BEFREE |
With an aim to determine the association of variations in <i>IGF2BP2</i> and <i>IGFBP3</i> genes with risk of non-small-cell lung cancer (NSCLC), <i>IGF2BP2</i> rs1470579 A>C, rs4402960 G>T and <i>IGFBP3</i> rs2270628 C>T, rs3110697 G>A, and rs6953668 G>A polymorphisms were selected and genotyped in 521 NSCLC patients and 1,030 controls.
|
30214291 |
2018 |
|
rs4743325
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A 2-tSNP AT haplotype reconstructed with tSNP rs7040869 and rs4743325, in linkage disequilibrium with each other, was strongly associated with NSCLC cases displaying ASE (P=0.01).
|
21225232 |
2011 |
|
rs6122390
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Additionally, the combined analysis of these 5 SNPs showed a significant locus-dosage effect between number of unfavorable alleles (rs919968-A, rs3775815-C, rs4867902-G, rs6122390-A, and rs298206-T) and death risk of NSCLC (P for trend < 0.001).
|
26632718 |
2015 |